Airsonett signs agreement with the region of Kalmar in Sweden for treatment of severe allergic asthma with TLA via public healthcare

Dokument -

Airsonett signs agreement with the region of Kalmar in Sweden for treatment of severe allergic asthma with TLA via public healthcare

Airsonett announced today that the company has signed an agreement with the region of Kalmar for the treatment of patients with severe allergic asthma. The agreement is the third for Airsonett in Sweden this year, for prescription of the company's unique treatment; Temperature controlled Laminar Airflow (TLA). The technology treats severe allergic asthma patients with particle-free air.
  • Licens: Medieanvändning
    Innehållet får laddas ner, användas och delas i olika mediekanaler av t.ex. journalister, bloggare, krönikörer, opinionsbildare etc., i syftet att förmedla, redogöra för och kommentera ert pressmeddelande, inlägg eller information, så länge innehållet används oförändrat och i dess helhet. Upphovsmannen ska anges i den omfattning och på det sätt god sed kräver (vilket bl.a. innebär att fotografer till bilder nästan alltid måste anges).
  • Filformat: .pdf
Ladda ner

Relaterat innehåll

Airsonett signs agreement with the region of Kalmar in Sweden for treatment of severe allergic asthma with TLA via public healthcare

Airsonett announced today that the company has signed an agreement with the region of Kalmar for the treatment of patients with severe allergic asthma. The agreement is the third for Airsonett in Sweden this year, for prescription of the company's unique treatment; Temperature controlled Laminar Airflow (TLA). The technology treats severe allergic asthma patients with particle-free air.